HomeTDAC • NASDAQ
add
Translational Development Acquisitin Crp
Previous close
$10.17
Day range
$10.17 - $10.17
Year range
$10.00 - $10.20
Market cap
222.80M USD
Avg Volume
54.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 347.41K | 41,110.91% |
Net income | 1.48M | 176,028.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 206.60K | 186.86% |
Total assets | 176.60M | 241,577.61% |
Total liabilities | 182.54M | 31,242.18% |
Total equity | -5.94M | — |
Shares outstanding | 4.66M | — |
Price to book | -7.95 | — |
Return on assets | -0.49% | — |
Return on capital | 15.05% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.48M | 176,028.11% |
Cash from operations | -231.57K | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -231.57K | -761.64% |
Free cash flow | -101.30K | — |
About
Founded
2022
